MOJ
eISSN: 2373-4442
Submit manuscript...
Mini Review Volume 7 Issue 1
New developments in type of hereditary angioedema with normal CI-inhibitor level
Oner Ozdemir
Department of Pediatrics, Sakarya University, Turkey
Received: February 15, 2019 | Published: February 19, 2019
Citation: Ozdemir O. New developments in type of hereditary angioedema with normal CI-inhibitor level. MOJ Immunol. 2019;7(1):1-2 DOI: 10.15406/moji.2019.07.00254
Abstract
In this mini-review, new developments in hereditary angioedema with normal C1- inhibitor level (HAE-nC1-INH) in 2018 will be briefly told. The first description of its hereditary form has been defined by Osler in 1888. The biochemical reflection of disease was explained by Donaldson and Evans in 1963. In the recent past, there have been three types of hereditary angioedema defined as type I-type III. However, the disease is presently categorized into 2 types in accordance with the C1-inhibitor function: hereditary angioedema with C1-INH deficiency (HAE-C1-INH) and HAEnC1-INH.
Keywords: Hereditary angioedema, Cl-Inhibitor level, Plasminogen, Angiopoietin-1, angioedema, plasminogen gene, glycoprotein, De novo mutations, glycoprotein, kringle, biochemical reflection
©2019 Ozdemir. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.
Citations
Media Partner & Supporters
